Trial · NCT02405091
Results by group27
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 27
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Monitored for Long-Term Safety of Valbenazine | Valbenazine 40mg | 45 | Participants | ||
| Number of Participants Monitored for Long-Term Safety of Valbenazine | Valbenazine 80mg | 107 | Participants | ||
| Number of Participants Monitored for Long-Term Safety of Valbenazine | Valbenazine 80/40mg | 11 | Participants | ||
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline at Week 48; On-site AIMS Raters | Valbenazine 40mg | -10.2 | Standard Error 1.2 | score on a scale | |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline at Week 48; On-site AIMS Raters | Valbenazine 80mg | -11.0 | Standard Error 0.5 | score on a scale | |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline at Week 48; On-site AIMS Raters | Valbenazine 80/40mg | -7.2 | Standard Error 2.2 | score on a scale | |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 40mg | At Baseline | 10.2 | Standard Error 0.6 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80mg | At Baseline | 10.0 | Standard Error 0.4 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80/40mg | At Baseline | 9.3 | Standard Error 0.8 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 40mg | Change from Baseline at Week 8 | -4.5 | Standard Error 0.7 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80mg | Change from Baseline at Week 8 | -3.5 | Standard Error 0.4 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80/40mg | Change from Baseline at Week 8 | -4.9 | Standard Error 1.2 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 40mg | Change from Baseline at Week 52 | -1.8 | Standard Error 1.0 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80mg | Change from Baseline at Week 52 | -3.3 | Standard Error 0.5 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; Central AIMS Video Raters | Valbenazine 80/40mg | Change from Baseline at Week 52 | 0.2 | Standard Error 1.3 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; On-Site AIMS Raters | Valbenazine 40mg | At Baseline | 14.2 | Standard Error 0.8 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; On-Site AIMS Raters | Valbenazine 80mg | At Baseline | 15.0 | Standard Error 0.4 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; On-Site AIMS Raters | Valbenazine 80/40mg | At Baseline | 12.8 | Standard Error 1.4 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; On-Site AIMS Raters | Valbenazine 40mg | Change from Baseline at Week 8 | -7.1 | Standard Error 1.0 | score on a scale |
| Severity of Tardive Dyskinesia (TD) Symptoms Assessed by Abnormal Involuntary Movements Scale (AIMS) Dyskinesia Total Score Change From Baseline; On-Site AIMS Raters | Valbenazine 80mg | Change from Baseline at Week 8 | -5.4 | Standard Error 0.5 | score on a scale |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02405091/results